Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), held a ribbon-cutting ceremony to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey. Joining Made Scientific were representatives from the offices of U.S. Senator Andy Kim and Congresswoman Bonnie Watson Coleman, who presented a proclamation, along with other federal, state, and local partners. The event marked a major milestone for the company and the region, underscoring New Jersey's role in the growing national landscape of advanced biomanufacturing and cell and gene therapy innovation
"Made Scientific's investment in Plainsboro Township is a testament to how New Jersey continues to lead the nation in life sciences and advanced biomanufacturing," said Governor Phil Murphy. "Investing in this new facility creates good-paying, high-quality jobs for New Jerseyans. We are proud of companies like Made Scientific that are fueling the advancement of life-saving therapies and driving our innovation economy forward."
"We are very pleased that Made Scientific, a leading cell therapy CDMO, has made the decision to locate its new headquarters and GMP manufacturing facility here in Plainsboro. It reinforces the strength of our town and workforce that locating in Plainsboro is a positive decision for Made Scientific and other pharma and biotech companies," said Mayor Edmund Yates. "We know that Made Scientific will have a transformative impact in the development and manufacturing of breakthrough medicines for patients worldwide. We welcome other similar companies to join Made Scientific in Plainsboro."
The opening marks the completion of a $12 million initial investment in facility upgrades, equipment, and business system digitization, strengthening Made Scientific's position in the rapidly growing cell therapy sector and commitment to building long-term manufacturing capacity to support the next generation of cell therapies globally. A second phase of expansion has already been announced, and the company is expected to grow its workforce with more than 100 additional skilled professionals, strengthening the company's regional presence and industry influence.
"Today is more than a ribbon cutting. It is a clear signal of our commitment to this incredible industry and to this region," said Syed T. Husain, Chairman and CEO of Made Scientific. "This facility is a testament to our dedication to supporting the next generation of cell therapy innovators for clinical-to-commercial manufacturing, all under one roof. With a globally compliant infrastructure, high-throughput GMP capacity, and a world-class team built for precision and speed, we are here to help our partners bring transformative therapies to patients with confidence and efficiency."
.
Comments powered by CComment